Skip to content
TrustList
Linden Capital Partners logo
Venture capital firm

Linden Capital Partners

Chicago private equity firm investing only in middle-market healthcare and life science companies

Linden Capital Partners cover

TrustList summary

Linden Capital Partners is a private equity firm based in Chicago that concentrates entirely on healthcare. It works with company management and with operating partners to grow the businesses it buys into.

Products and services

  • Healthcare private equity: ownership investments in developing middle-market healthcare and life science companies.
  • Value Creation Program: a structured programme through which the firm works with management to grow portfolio companies.
  • Operating partners: experienced operators who stay closely involved with each company.
  • Structured capital: a dedicated partner role covering this form of financing.

Clients

The firm partners with company management teams, business owners and investors in the healthcare and life science sectors. Recent announcements cover a pharmacy group, medical products and dental education businesses.

Key facts

  • Based in: Chicago, USA
  • Founded: 2004
  • Focus: Healthcare and life sciences only

Summary written by TrustList from the business's own published information, Sep 2026.

Categories & features

Rankings

Linden Capital Partners is ranked on 3 TrustList rankings: #10 on 1, #14 on 1 and #19 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Linden Capital Partners has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 3 rankings

  • #10of 87
    Chicago

    It is the only one of the top 65 here listing dental and one of 2 here listing medical.

    Its profile: “Linden Capital Partners is a private equity firm based in Chicago that concentrates entirely on healthcare.”

    Of the top 65 here, 13 also cover partners and 8 also cover series a; 26 also work in New York City and 19 also work in San Francisco.

    Behind One Equity Partners, ahead of Accel-KKR.

  • #14of 59
    Private equity firms

    It is the only one of the top 57 here listing peer-to-peer and one of 2 here listing driving.

    Of the top 57 here, 12 also cover healthtech and 6 also cover growth stage; 8 also work in London and 5 also work in Chicago.

    Behind Waypoint Capital Partners, ahead of Fortissimo Capital.

  • #19of 147
    Healthtech investors

    It is the only one of the top 64 here listing legal and one of 2 here listing education.

    Of the top 64 here, 14 also cover biotech and 13 also cover seed stage; 7 also work in Boston and 6 also work in Silicon Valley.

    Behind Norwich Ventures, ahead of Big Issue Invest.

As of 2026-11-02. Organic ranks only; sponsored placements are never ranks. How TrustList ranks

What the business tells TrustList

Founded
2004 (22 years) evidence sent

Ask TrustList to introduce you to Linden Capital Partners

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Linden Capital Partners

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Linden Capital Partners.

Linden Capital Partners alternatives

Similar listings buyers compare against this one.

An investment firm active in the US and Southeast Asia across private companies, public equities, real estate and funds

Merchant and investment banking boutique combining venture investing with financial advisory

Venture investor backing Portuguese and Spanish technology and sustainability companies from seed to Series A

A Swiss private investment company backing digital assets and founders since 1997

Global investment firm putting capital into consumer, technology and financial services companies alongside social initiatives

Early-stage investor supporting capital-efficient founders in North America from pre-seed to Series B